Vasodilatory Shock

• FDA approval · 2025-06-03
  FDA Approved: ANGIOTENSIN II — Original Application (Gland Pharma Limited)

  FDA approved Gland Pharma Limited's Angiotensin II under an Original Application (ANDA216966).

• FDA approval · 2024-07-11
  FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Long Grove Pharmaceuticals, LLC)

  FDA approved VASOPRESSIN IN 0.9% SODIUM CHLORIDE from Long Grove Pharmaceuticals as an original NDA for vasopressin injection to be used as …

• FDA approval · 2024-02-09
  FDA Approved: VASOPRESSIN — Original Application (Sagent Pharmaceuticals)

  FDA approved the original application for a generic vasopressin product from Sagent Pharmaceuticals.

• FDA approval · 2023-09-29
  FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)

  The FDA granted approval for Baxter’s vasopressin in 0.9% sodium chloride under an Original Application (NDA).

• FDA approval · 2023-07-21
  FDA Approved: VASOPRESSIN — Supplemental Application (Amneal Pharmaceuticals LLC)

  FDA approves Amneal's supplemental application for Vasopressin under ANDA212944, authorizing changes to the approved generic product.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2022-08-15
  FDA Approved: VASOPRESSIN — Original Application (Eugia US LLC)

  FDA approved the original application for VASOPRESSIN from Eugia US LLC, a generic vasopressin product. It is indicated for use as a vasopre…

• FDA approval · 2021-03-15
  FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC.

• CLINICAL_TRIALS approval · 2018-03-08
  Clinical Trial Update: Expanded Access for LJPC-501

  La Jolla Pharmaceutical Company's LJPC-501 has been approved for marketing to treat catecholamine-resistant hypotension and distributive sho…

• FDA approval · 2016-12-17
  FDA Approved: VASOSTRICT — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for Vasostrict (vasopressin) submitted by Par Health USA, LLC. This action concerns the approval of …

• FDA approval · 2014-04-17
  FDA Approved: VASOSTRICT — Original Application (Par Health USA, LLC)

  The FDA granted approval for VASOSTRICT (vasopressin) through an Original Application from Par Health USA, LLC. It is approved as a vasopres…